Market Cap
$2.22 B
+$193.49 M+9.56%
116 min ago
Summary
- As of March 5, 2025, LGND market capitalization is $2.22 billion, with a rise of +$193.49 million (+9.56%) during the most recent trading day.
- Over the past year, LGND market cap has increased by +$854.24 million (+62.67%).
- LGND market cap is now -61.72% below its all-time high of $5.79 billion.
Performance
LGND Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Related metrics
Market Cap Formula
Market Cap = Price ✕ Shares Outstanding
LGND Market Cap Trends
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
|---|---|---|---|---|
| todaytoday | +9.6% | +9.6% | +0.7% | +9.9% |
| 1 m1 month | +0.1% | +0.1% | - | - |
| 3 m3 months | -3.0% | -3.0% | - | -3.5% |
| 6 m6 months | +21.0% | +17.0% | - | +18.1% |
| ytdytd | +9.7% | +9.7% | - | - |
| 1 y1 year | +62.7% | +52.4% | +6.7% | +59.9% |
| 5 y5 years | +24.5% | +8.8% | +14.5% | -8.8% |
LGND Market Cap Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -5.8% | $2.02 B | +9.6% | |
| 3 m | 3-month | $2.37 B | -6.5% | $1.89 B | +17.3% |
| 6 m | 6-month | $2.49 B | -11.1% | $1.78 B | +24.6% |
| 1 y | 1-year | $2.49 B | -11.1% | $1.19 B | +86.2% |
| 3 y | 3-year | $2.49 B | -11.1% | $864 M | +156.8% |
| 5 y | 5-year | $3.47 B | -36.1% | $864 M | +156.8% |
| alltime | all time | $5.79 B | -61.7% | $102 M | +2064.0% |
Ligand Pharmaceuticals Incorporated Market Cap History
| Date | Value |
|---|---|
| 2025 | $2.22 B(+9.7%) |
| 2024 | $2.02 B(+61.1%) |
| 2023 | $1.26 B(+10.9%) |
| 2022 | $1.13 B(-56.3%) |
| 2021 | $2.59 B(+61.9%) |
| 2020 | $1.60 B(-8.9%) |
| 2019 | $1.75 B(-37.7%) |
| 2018 | $2.82 B(-2.7%) |
| 2017 | $2.90 B(+36.3%) |
| 2016 | $2.12 B(-1.8%) |
| 2015 | $2.16 B(+107.6%) |
| 2014 | $1.04 B(-3.3%) |
| 2013 | $1.08 B(+144.0%) |
| 2012 | $441.32 M(+90.0%) |
| 2011 | $232.23 M(+33.4%) |
| Date | Value |
|---|---|
| 2010 | $174.02 M(-31.3%) |
| 2009 | $253.16 M(-2.7%) |
| 2008 | $260.14 M(-42.9%) |
| 2007 | $455.37 M(-58.2%) |
| 2006 | $1.09 B(+33.7%) |
| 2005 | $814.65 M(-4.1%) |
| 2004 | $849.38 M(-21.0%) |
| 2003 | $1.08 B(+180.2%) |
| 2002 | $383.68 M(-64.3%) |
| 2001 | $1.08 B(+35.4%) |
| 2000 | $794.50 M(+16.4%) |
| 1999 | $682.60 M(+28.5%) |
| 1998 | $531.13 M(+7.1%) |
| 1997 | $495.73 M(+4.8%) |
| 1996 | $473.01 M(+145.1%) |
| 1995 | $193.00 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated market capitalization?
- What is the all time high market cap for Ligand Pharmaceuticals Incorporated?
- What is LGND market capitalization year-to-date change?
- What is Ligand Pharmaceuticals Incorporated market cap year-on-year change?
What is Ligand Pharmaceuticals Incorporated market capitalization?
The current market cap of LGND is $2.22 B
What is the all time high market cap for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high market capitalization is $5.79 B
What is LGND market capitalization year-to-date change?
Ligand Pharmaceuticals Incorporated market capitalization has changed by +$195.38 M (+9.66%) since the beginning of the year
What is Ligand Pharmaceuticals Incorporated market cap year-on-year change?
Over the past year, LGND market capitalization has changed by +$854.24 M (+62.67%)